Evolent Health Files 8-K
Ticker: EVH · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1628908
| Field | Detail |
|---|---|
| Company | Evolent Health, INC. (EVH) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $140.0 million, $21.75 million, $145.0 million, $166.75 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: EVH
TL;DR
EVH filed an 8-K on 8/19 for 8/18 events - looks like standard financial disclosures.
AI Summary
Evolent Health, Inc. filed an 8-K on August 19, 2025, reporting on events that occurred on August 18, 2025. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure rather than a specific material event.
Why It Matters
This 8-K filing by Evolent Health, Inc. serves as a public record of corporate events and financial disclosures, important for investors and analysts tracking the company's activities.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, not indicating any immediate significant risks or changes.
Key Players & Entities
- Evolent Health, Inc. (company) — Registrant
- August 18, 2025 (date) — Date of earliest event reported
- August 19, 2025 (date) — Date of report
- 001-37415 (company) — Commission file number
- 32-0454912 (company) — I.R.S. Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' for Evolent Health, Inc., with the earliest event reported on August 18, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on August 19, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Evolent Health, Inc.
What is the principal executive office address for Evolent Health, Inc.?
The principal executive office address is 1812 N. Moore Street, Suite 1705, Arlington, Virginia 22209.
What is the telephone number for Evolent Health, Inc.?
The telephone number for Evolent Health, Inc. is (571) 389-6000.
Filing Stats: 820 words · 3 min read · ~3 pages · Grade level 10 · Accepted 2025-08-19 08:14:45
Key Financial Figures
- $0.01 — tock of Evolent Health, Inc., par value $0.01 per share EVH New York Stock Exchan
- $140.0 million — of its previously announced offering of $140.0 million aggregate principal amount of 4.50% con
- $21.75 million — option to purchase up to an additional $21.75 million aggregate principal amount of notes. Th
- $145.0 million — of the offering from $140.0 million to $145.0 million (or $166.75 million if the initial purc
- $166.75 million — om $140.0 million to $145.0 million (or $166.75 million if the initial purchasers' option to pu
- $100.2 million — he Company expects to use approximately $100.2 million of the net proceeds from the offering,
- $167.4 million — liquidity, to repurchase approximately $167.4 million aggregate principal of its 1.50% conver
- $167.6 million — 25 (the "2025 Notes") for approximately $167.6 million in cash in note repurchases entered int
- $40.0 million — mpany also expects to use approximately $40.0 million of the net proceeds from the offering t
- $0 — common stock of the Company, par value $0.01, issuable upon conversion of the not
Filing Documents
- d30469d8k.htm (8-K) — 28KB
- d30469dex991.htm (EX-99.1) — 17KB
- g30469g0816032936064.jpg (GRAPHIC) — 6KB
- 0001193125-25-183075.txt ( ) — 171KB
- evh-20250818.xsd (EX-101.SCH) — 3KB
- evh-20250818_lab.xml (EX-101.LAB) — 18KB
- evh-20250818_pre.xml (EX-101.PRE) — 11KB
- d30469d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release of Evolent Health, Inc. dated August 19, 2025 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EVOLENT HEALTH, INC. Date: August 19, 2025 By: /s/ Jonathan D. Weinberg Name: Jonathan D. Weinberg Title: General Counsel and Secretary